|
 |
pamidronate disodiumThis page contains recent news articles, when available, and an overview of pamidronate disodium but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Pamidronate Disodium Injection is indicated for the treatment of hypercalcemia ... Recent IMS data estimates an annual market size for Pamidronate Disodium ... Genetic Engineering News - Genetic Engineering News (press release) Press Release: /CORRECTION -- Barr Pharmaceuticals, Inc. (NYSE: BRL) … - Aug 21, 2008 Article: Akorn-Strides Gets FDA OK for Pamidronate Disodium ... ... The company said Pamidronate Disodium Injection is indicated for the treatment ... ... Pay-Per-View - PR Newswire - HighBeam Research A different schedule of zoledronic acid can reduce the risk of the … - Apr 5, 2007 Monthly infusions of pamidronate disodium, a second-generation bisphosphonate, given in addition to anti-myeloma therapy, significantly reduced skeletal ... Nature.com Intravenous Bisphosphonates Linked to ONJ in Cancer Patients, FDA … - May 19, 2005 The FDA has received reports of ONJ in cancer patients receiving treatment with IV bisphosphonates, including pamidronate disodium and zoledronic acid. ... Medscape Loislaw Federal District Court Opinions - IN RE AREDIA & ZOMETA … - Nov 30, 2007 Both Directors of Pharmacy have testified that their offices have the sole responsibility for purchasing drugs, including pamidronate disodium, for use at ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Drug management - May 13, 2006 1 There have also been recommendations made by an expert panel established by Novartis (manufacturer of pamidronate disodium (Aredia) and zolendronic acid ... Nature.com Prostate Cancer,Advanced or Metastatic - Medications - Jul 1, 2008 Bisphosphonate drugs such as alendronate (Fosamax), pamidronate disodium (Aredia), and zoledronic acid (Zometa) may help relieve bone pain and prevent ... WebMD Role of BMD studies, bisphosphonates in men on ADT: detecting, … - Apr 1, 2007 In an early study of a single infusion of pamidronate disodium (Aredia), 90 mg, in men receiving ADT, serum levels of metaboric markers of osteolysis were ... Free with registration - Urology Times - AccessMyLibrary.com Osteonecrosis of the jaw risk low, but not zero, among oral … - Sep 1, 2006 Ninety-four percent of those patients were treated with IV bisphosphonates such as pamidronate disodium (Aredia, Novartis) and zoledronic acid (Zometa, ... Endocrine Today Patients receiving intravenous bisphosphonates should avoid invasive ... - Jun 21, 2005 Updated safety: possible relationship of Aredia (pamidronate disodium) and/or Zometa (zoledronic acid) with osteonecrosis of the jaw [letter to health care ... Free with registration - CMAJ: Canadian Medical Association... - AccessMyLibrary.com Randomized Trial Shows Ganite(R) Effective When Compared with a … - Mar 2, 2006 ...double- blind, Phase 2 trial that showed Ganite(R) (gallium nitrate injection) was highly effective when compared with Aredia(R) (pamidronate disodium; ... Free with registration - PR Newswire - AccessMyLibrary.com Bisphosphonates can damage jaw.(News) - Apr 15, 2005 ...as well as from Novartis, which manufactures the intravenous bisphosphonates pamidronate disodium (Aredia) and zoledronic acid (Zometa). ... Free with registration - Internal Medicine News - AccessMyLibrary.com Bisphosphonate warning.(Shorts) - Apr 1, 2005 In December 2004, Novartis released a warning concerning two of its bisphosphonate drugs: Zometa (zoledronic acid) and Aredia (pamidronate disodium). ... Free with registration - Townsend Letter for Doctors and Patients - AccessMyLibrary.com Market Gainer Begins coverage on Genta Inc. - Mar 2, 2006 ...double- blind, Phase 2 trial that showed Ganite (gallium nitrate injection) was highly effective when compared with Aredia (pamidronate disodium; ... Free with registration - M2 Presswire - AccessMyLibrary.com Problems Requiring Local Treatment - Jul 28, 2008 Your doctor may prescribe either Aredia (chemical name: pamidronate disodium) or Zometa (chemical name: zolendroic acid). Both are put into your blood with ... Breastcancer.org Risedronate averts breast cancer-related bone loss - Feb 7, 2007 Other bisphosphonates, such as Zometa (zoledronic acid) and Aredia (chemical name: pamidronate disodium), are sometimes given intravenously to women being ... Breastcancer.org Pain Management - Jul 18, 2008 Bone pain can also be relieved with the bone-strengthening medicines Zometa (chemical name: zoledronic acid) or Aredia (chemical name: pamidronate disodium) ... Breastcancer.org New generics.(drug approvals) - Oct 24, 2005 Pamidronate disodium injection, Sicor Pharmaceuticals, Irvine, Calif., (800) 729-9991, is approved as alternate therapy to Novartis' Aredia for Intravenous ... Free with registration - Drug Topics - AccessMyLibrary.com New Jersey Administrative Code - 10:58A-4.3 HCPCS procedure codes … - Aug 16, 2005 2.95 (Numorphan), up to 1 mg J2430 Injection, pamidronate disodium, per 279.86 30 mg J2440 Injection, papaverine HCI, up to 60 mg 8.32 J2460 Injection, ... Pay-Per-View - New Jersey Administrative Code - Loislaw Press Release: Mylan Announces Tentative FDA Approval for Letrozole … - May 3, 2007 ...(letrozole tablets) as first-line therapy in postmenopausal women with ... pamidronate disodium for injection) and Femara(R) (letrozole tablets). ... Pay-Per-View - PR Newswire - HighBeam Research An unrecognized cause of recurrent hypercalcemia: immobilization.(Case... - Apr 1, 2006 IV infusion of pamidronate disodium 90 mg and saline hydration with 2000 mL per day, together with a rehabilitative program, began on the 25th hospital day. ... $4.95 - Southern Medical Journal - ECNext Mayne Pharma (USA), Paramus, NJ, Feb. 1, (New Jersey).(Human Drugs … - Mar 1, 2005 No quarterly periodic ADE reports within 30 days of the close of the quarter were submitted for the following: pamidronate disodium injection, ... $4.95 - Warning Letter Bulletin - ECNext United States Code of Federal Regulations - 42 CFR § 414.707 Basis of... - Jul 12, 2006 GOSERELIN ACETATE 80 RITUXIMAB 81 PACLITAXEL 81 DOCETAXEL 80 CARBOPLATIN 81 IRINOTECAN 80 GEMCITABINE HCL 80 PAMIDRONATE DISODIUM 85 DOLASETRON MESYLATE ... Pay-Per-View - United States Code of Federal Regulation... - Loislaw New York Miscellaneous Reports - STREIMER v. BIONDO, 108374/06 ( … - Oct 21, 2008 We are writing to inform you of changes made to the Precautions and Post-Marketing Experience sections of the Aredia (pamidronate disodium) Injection and ... Pay-Per-View - New York Miscellaneous Reports - Loislaw Zoledronic acid reduces risk of recurrent fracture. | Article from... - Dec 1, 2007 ...zoledronic acid (Zometa) and pamidronate disodium (Aredia) can lead to a rare and potentially serious jaw condition called osteonecrosis ... ... Pay-Per-View - Focus on Healthy Aging - HighBeam Research Top 200 drugs used in hospitals in 2006.(Table) - Apr 16, 2007 51705706.98 -17.91 171 Lovastatin 51410610.67 31.68 172 Avonex 51264046.50 9.30 173 Pamidronate Disodium 50969160.89 -17.08 174 Simvastatin 50621992.50 ... $4.95 - Drug Topics - ECNext Article: Solutions and Dilutions.(chimistry education) - Science... - Mar 1, 2006 PR Newswire; October 28, 2002 ; 624 words ... ... announced today it will make available a 60mg/10 mL dosage of Pamidronate disodium solution. ... Pay-Per-View - Science Scope - HighBeam Research Press Release: Stakeholder Opinions: Bone Metastases Presents Current... - Apr 25, 2008 LTD RDATE ... significant difference favoring Zometa when compared with the current treatment standard, Aredia (pamidronate disodium for injection ... ... Pay-Per-View - M2 Presswire - HighBeam Research Bisphosphonate-associated scleritis: a case report and review.(Case … - Jul 1, 2005 ...(similar diagnosis as in our patient) associated with pamidronate disodium collected from reports submitted to the World Health Organization (Uppsala, ... $4.95 - Southern Medical Journal - ECNext Company Profile Report - Sep 13, 2008 Products:. Pamidronate Disodium. Hypokalemia. Potassium Supplements. Products:. Potassium Chloride. Immunology. Autoimmune Disorders. Arthritis ... $50.00 - Revere Reports - Revere Press Release: Randomized Trial Shows Ganite(R) Effective When … - Mar 2, 2006 ...double- blind, Phase 2 trial that showed Ganite(R) (gallium nitrate injection) was highly effective when compared with Aredia(R) (pamidronate disodium; ... Pay-Per-View - PR Newswire - HighBeam Research Federal Register 2005 - 70 FR 6016 Oncologic Drugs Advisory … - Feb 4, 2005 NDA 21-223, ZOMETA (zoledronic acid) Injection and AREDIA (pamidronate disodium for injection), both from Novartis Pharmaceuticals Corp. ... Pay-Per-View - Federal Register 2005 - Loislaw Ask Dr. Leipzig. | Article from Focus on Healthy Aging | HighBeam … - Mar 1, 2006 ...zoledronic acid (Zometa) and pamidronate disodium (Aredia) can lead to a rare and potentially serious jaw condition called osteonecrosis. ... Pay-Per-View - Focus on Healthy Aging - HighBeam Research Osteonecrosis; Doctors link common chemotherapy drug to jawbone … - Jan 8, 2005 Novartis's Aredia (pamidronate disodium) and Zometa (zoledronic acid) injections are the two intravenous bisphophosphonates used in chemotherapy regimens. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Press Release: Market Gainer Begins coverage on Genta Inc. - M2 … - Mar 2, 2006 ...double- blind, Phase 2 trial that showed Ganite (gallium nitrate injection) was highly effective when compared with Aredia (pamidronate disodium; ... Pay-Per-View - M2 Presswire - HighBeam Research New generics. - Oct 24, 2005 Pamidronate disodium injection, Sicor Pharmaceuticals, Irvine, Calif., (800) 729-9991, is approved as alternate therapy to Novartis' Aredia for Intravenous ... $9.94 - Drug Topics - Alacra Store FDA revises package inserts to improve safety.(News) | Article from... - Mar 1, 2006 OB GYN News; April 15, 2005 ; 700+ words ... ... intravenous bisphosphonates pamidronate disodium (Aredia) and zoledronic acid (Zometa). ... Pay-Per-View - OB GYN News - HighBeam Research Article: Bisphosphonate warning.(Shorts) - Townsend Letter for... - Apr 1, 2005 In December 2004, Novartis released a warning concerning two of its bisphosphonate drugs: Zometa (zoledronic acid) and Aredia (pamidronate disodium). ... Pay-Per-View - Townsend Letter for Doctors and Patients - HighBeam Research Article: With $65M plant under way, Ben Venue plots next project. - … - Nov 21, 2005 ...of Ben Venue Laboratories Inc. in Bedford, said it received FDA approval to offer the first generic version of Pamidronate Disodium for Injection ... ... Pay-Per-View - Crain's Cleveland Business - HighBeam Research Mayne Pharma Gets Warning Letter for Failing to Report Adverse Events - Mar 9, 2005 13 and Oct. 6, 2004, found similar reporting problems with the company's pamidronate disodium solution, methotrexate sodium injection and cytarabine ... Pay-Per-View - FDAnews Drug Daily Bulletin - Factiva, from Dow Jones Treatment of oncologic emergencies.(Clinical report) - Dec 1, 2006 Longterm efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced ... $4.95 - American Family Physician - ECNext New products target variety of ailments. - Oct 24, 2005 Sicor Pharmaceutical Sales Inc. It has introduced pamidronate disodium injection. The product has the same therapeutic effect as Novartis Pharmaceuticals ... $9.94 - Chain Drug Review - Alacra Store Long-term bisphosphonate use may damage jaw.(News) | Article from OB … - Apr 15, 2005 ...as well as from Novartis, which manufactures the intravenous bisphosphonates pamidronate disodium (Aredia) and zoledronic acid (Zometa). ... Pay-Per-View - OB GYN News - HighBeam Research Bifosfonaten aan de basis van kaaknecrose? - Dec 18, 2006 Het gaat om pamidronate disodium en zoledronic acid. Predisponerende factoren Volgens Bilezikian bestaat de werking van deze geneesmiddelen erin dat ze de ... دستناسيون سنتي - دستناسيون سنتي |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |